Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...
BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...
A phase 3 clinical trial has shown that patients were 32 per cent less likely to experience cancer recurrence when treated ...
A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder ...
Increased survival rates’ for bladder cancer patients given immunotherapy drug - Experts said Durvalumab could be a ‘game ...
Despite being given a cruel, short death sentence, this Noosa father-of-three refuses to give up and graciously says his ...
FOR the 6,000 people in the UK who are newly diagnosed with bile duct cancer every year, the prognosis is uniquely grim.
A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue-some as ...
UroGen Pharma (URGN) announced that the three-month complete response rate and 12-month durability of response from the Phase 3 ENVISION study ...
In December 2024, the Company reported positive interim results from its ongoing Phase 2 open-label ADVANCED-2 trial in in ...